Variable Adherence To HCV Treatment Among People Who Inject Drugs Treated with 8 Versus
12 Weeks of Antiviral Therapy Resulted In High Rates of SVR
AASLD 2020 virtual Nov 11-16
Reported by Jules Levin
Tiberiu Moga, MD, Naren Nallapeta, MD and Anthony Martinez, MD
University at Buffalo (The State University of New York) and Department of Gastroenterology and Hepatology at Erie County Medical Center, Buffalo, NY USA
Since several other studies have shown missing up to I think I recall 50% missed doses does not prevent HCV SVR I suspect these failures missed 5 days lapse of dosing:
Variable adherence was defined as having documentation of >5 doses missed or a >5 day lapse in treatment.